|
V31993
|
E3 Ligase Ligand-Linker Conjugates 14 free base
|
1957236-20-2 |
Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is a ligand (for E3 ligase )-linker conjugate containing a Thalidomide-based cereblon ligand and a 3-unit PEG linker. |
|
V32228
|
E3 Ligase Ligand-Linker Conjugates 19
|
1799711-24-2 |
Thalidomide-O-amido-C4-NH2 (Cereblon Ligand-Linker Conjugates 6) is a ligand (for E3 ligase )-linker conjugate containing a Thalidomide-based cereblon ligand and 1 linker, may be utilized to prepare PROTAC protein degraders. |
|
V32006
|
E3 Ligase Ligand-Linker Conjugates 20
|
1950635-15-0 |
Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2) is a ligand (for E3 ligase )-linker conjugate containing a Thalidomide-based cereblon ligand and 1 linker, may be utilized to prepare PROTAC protein degraders. |
|
V31522
|
E3 Ligase Ligand-Linker Conjugates 22
|
2225940-52-1 |
E3 Ligase Ligand-Linker Conjugates 22 is a novel E3 ligase ligand and linker cpnjugate composed of an E3 ligase ligand (Pomalidomide-PEG4-C2-NH2) and a linker. |
|
V31994
|
E3 Ligase Ligand-Linker Conjugates 24 TFA
|
1957235-75-4 |
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a ligand (for E3 ligase )-linker conjugate containing a Thalidomide-based cereblon ligand and a 2-unit PEG linker. |
|
V32007
|
E3 Ligase Ligand-Linker Conjugates 25 TFA
|
1950635-14-9 |
Thalidomide-O-amido-C6-NH2 TFA (Cereblon Ligand-Linker Conjugates 11 TFA) is a ligand (for E3 ligase )-linker conjugate containing a Thalidomide-based cereblon ligand and 1 linker, may be utilized to prepare PROTAC protein degraders. |
|
V31720
|
E3 ligase Ligand-Linker Conjugates 29
|
2098836-63-4 |
VH032-thiol-C6-NH2 (VHL Ligand-Linker Conjugates 14) is a ligand (for E3 ligase )-linker conjugate containing a VHL ligand based on VH032 and 1 linker. |
|
V31765
|
E3 ligase Ligand-Linker Conjugates 30
|
2093416-31-8 |
Pomalidomide-PEG3-C2-NH2 is a ligand (for E3 ligase )-linker conjugate, which contains a Pomalidomide-based cereblon ligand and a 3-unit PEG linker. |
|
V31767
|
E3 ligase Ligand-Linker Conjugates 31
|
2093388-45-3 |
E3 ligase Ligand-Linker Conjugates 31 is a novel and potent Ligand |
|
V31310
|
E3 ligase Ligand-Linker Conjugates 49
|
2351103-63-2 |
Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH is a ligand (for E3 ligase )-linker conjugate containing a Pomalidomide-based cereblon ligand and 1 linker. |
|
V32151
|
(S,R,S)-AHPC-PEG2-C4-Cl
|
1835705-57-1 |
(S,R,S)-AHPC-PEG2-C4-Cl (VH032-PEG2-C4-Cl) is a composite molecule connected by E3 ligand to 13 atoms, and the linker of the linker is a Halogen group. |
|
V32149
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl
|
1835705-61-7 |
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl is a small molecule HaloPROTAC containing (S,R,S)-AHPC-based VHL ligand and 2-unit PEG linker. |
|
V32236
|
(S,R,S)-AHPC-PEG3-N3
|
1797406-80-4 |
(S,R,S)-AHPC-PEG3-N3 is a ligand (for E3 ligase )-linker conjugate containing (S,R,S)-AHPC-based VHL ligand and 3-unit PEG linker . |
|
V32235
|
(S,R,S)-AHPC-PEG4-N3
|
1797406-81-5 |
(S,R,S)-AHPC-PEG4-N3 is a ligand (for E3 ligase )-linker conjugate containing (S,R,S)-AHPC-based VHL ligand and 4-unit PEG linker . |
|
V32152
|
(S,R,S)-AHPC-C6-PEG3-C4-Cl
|
1835705-55-9 |
(S,R,S)-AHPC-C6-PEG3-C4-Cl is a composite molecule connected by E3 ligand to 20 atoms, and the linker of the linker is a Halogen group. |
|
V32150
|
(S,R,S)-AHPC-PEG6-C4-Cl
|
1835705-59-3 |
(S,R,S)-AHPC-PEG6-C4-Cl (VH032-PEG6-C4-Cl) is a composite molecule connected by E3 ligand to 25 atoms, and the linker of the linker is a Halogen group. |
|
V32329
|
E4CPG
|
170846-89-6 |
E4CPG ((RS)-ECPG) is an antagonist of Group I/Group II metabotropic glutamate receptor. |
|
V32896
|
E6130
|
1427058-33-0 |
E6130 is an orally bioactive, selective modulator of CX3CR1 with the potential to study inflammatory bowel disease. |
|
V37811
|
E64FC26
|
2285446-62-8 |
E64FC26 is a potent pan-inhibitor of the protein disulfide isomerase (PDI) family, with IC50s of 1.9, 20.9, 25.9, 16.3 and 25.4 μM for PDIA1, PDIA3, PDIA4, TXNDC5 and PDIA6, respectively. |
|
V37853
|
EB-3D
|
1839150-63-8 |
EB-3D is a potent and specific choline kinase alpha (ChoKα) inhibitor (antagonist) with IC50 of 1 μM for ChoKα1. |